Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Venous Thrombosis 5 Venous Thromboembolism 3 Pulmonary Embolism 2 Thrombosis 1 Thromboembolism 1 Myeloproliferative Disorders 1 Hemostatic Disorders 1 Embolism 1

Interventions

dacetuzumab 2 Bortezomib 2 epratuzumab 1 edoxaban 1 Vorinostat 1 Ultrasonography 1 Tranexamic Acid 1 Tinzaparin 1 Saline Solution 1 Lenalidomide 1 Enoxaparin 1 Dipyrone 1 Dexamethasone 1 Calcium Dobesilate 1 Blood Specimen Collection 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemostatic Disorders × edoxaban × Clear all

NCT03570281 2018-06-26

ENCHASE

Samsung Medical Center

Phase 2/3 Unknown

Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡